Understanding the precise mechanisms of CD300E’s involvement in tumor immunity is critical for the development of novel immunotherapeutic strategies, which could include modulating its expression or function to enhance the immune system’s capacity to target tumors (28, 29). Here, CD300E is linked to neoplasm.